Leukemia 2014-07-01

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia.

F Ravandi, C Arana Yi, J E Cortes, M Levis, S Faderl, G Garcia-Manero, E Jabbour, M Konopleva, S O'Brien, Z Estrov, G Borthakur, D Thomas, S Pierce, M Brandt, K Pratz, R Luthra, M Andreeff, H Kantarjian

Index: Leukemia 28(7) , 1543-5, (2014)

Full Text: HTML

Abstract

Related Compounds

Related Articles:

Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth.

2014-01-01

[PLoS Biol. 12(1) , e1001758, (2014)]

Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.

2015-01-01

[Drug Des. Devel. Ther. 9 , 425-64, (2015)]

Functionalized tetrahydro-1H-pyrido[4,3-b]indoles: a novel chemotype with Sirtuin 2 inhibitory activity.

2015-03-06

[Eur. J. Med. Chem. 92 , 145-55, (2015)]

Identification and characterization of epithelial cells derived from human ovarian follicular fluid.

2015-01-01

[Stem Cell Res. Ther. 6 , 13, (2015)]

An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis.

2015-01-01

[Pediatr. Dermatol. 32(2) , 208-15, (2015)]

More Articles...